Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000315066-26-000651·Avalo Therapeutics, Inc.
Schedule 13G ownership disclosure
Avalo Therapeutics, Inc.
COMMON STOCK · CUSIP: 05338F306
Event date: 2026-02-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 2,125,819.00 · Class: 11.5%
- Abigail P. Johnson
Shares: 2,125,819.00 · Class: 11.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-26-000651
- Form type
- SCHEDULE 13G
- Filer
- Avalo Therapeutics, Inc.
- CIK
- CIK 1534120
- Filed
- Mar 06, 2026
- Reporting period
- Feb 27, 2026
- Description
- Schedule 13G beneficial ownership